Important
Updates
Senores Pharmaceuticals LimitedSENORES · Filed with the exchange
Senores Pharma's board approved an ESOS 2026 of 0.0472 Cr options for employees (subject to shareholder approval). The company also decided to incorporate wholly-owned subsidiaries in Mexico and Canada to expand its international market presence.
No comments yet. Be the first.